Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review

por Maurice Dror, Corinne, Chi, Kim N., Khalaf, Daniel J.
Publicado 2021

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience

por Moore, Assaf, Bar, Yael, Maurice-Dror, Corinne, Finkel, Inbar, Goldvaser, Hadar, Dudnik, Elizabeth, Goldstein, Daniel A., Gordon, Noa, Billan, Salem, Gutfeld, Orit, Wolf, Ido, Popovtzer, Aron
Publicado 2021

First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors

por Siu, Lillian L., Wang, Ding, Hilton, John, Geva, Ravit, Rasco, Drew, Perets, Ruth, Abraham, Anson K., Wilson, Douglas C., Markensohn, Julia F., Lunceford, Jared, Suttner, Leah, Siddiqi, Shabana, Altura, Rachel A., Maurice-Dror, Corinne
Publicado 2022

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes

por Ritch, Elie J., Herberts, Cameron, Warner, Evan W., Ng, Sarah W. S., Kwan, Edmond M., Bacon, Jack V. W., Bernales, Cecily Q., Schönlau, Elena, Fonseca, Nicolette M., Giri, Veda N., Maurice-Dror, Corinne, Vandekerkhove, Gillian, Jones, Steven J. M., Chi, Kim N., Wyatt, Alexander W.
Publicado 2023

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

por Muik, Alexander, Garralda, Elena, Altintas, Isil, Gieseke, Friederike, Geva, Ravit, Ben-Ami, Eytan, Maurice-Dror, Corinne, Calvo, Emiliano, LoRusso, Patricia M., Alonso, Guzman, Rodriguez-Ruiz, Maria E., Schoedel, Kristina B., Blum, Jordan M., Sänger, Bianca, Salcedo, Theodora W., Burm, Saskia M., Stanganello, Eliana, Verzijl, Dennis, Vascotto, Fulvia, Sette, Angelica, Quinkhardt, Juliane, Plantinga, Theo S., Toker, Aras, van den Brink, Edward N., Fereshteh, Mark, Diken, Mustafa, Satijn, David, Kreiter, Sebastian, Breij, Esther C.W., Bajaj, Gaurav, Lagkadinou, Eleni, Sasser, Kate, Türeci, Özlem, Forssmann, Ulf, Ahmadi, Tahamtan, Şahin, Uğur, Jure-Kunkel, Maria, Melero, Ignacio
Publicado 2022

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

por Sjöström, Martin, Zhao, Shuang G., Levy, Samuel, Zhang, Meng, Ning, Yuhong, Shrestha, Raunak, Lundberg, Arian, Herberts, Cameron, Foye, Adam, Aggarwal, Rahul, Hua, Junjie T., Li, Haolong, Bergamaschi, Anna, Maurice-Dror, Corinne, Maheshwari, Ashutosh, Chen, Sujun, Ng, Sarah W.S., Ye, Wenbin, Petricca, Jessica, Fraser, Michael, Chesner, Lisa, Perry, Marc D., Moreno-Rodriguez, Thaidy, Chen, William S., Alumkal, Joshi J., Chou, Jonathan, Morgans, Alicia K., Beer, Tomasz M., Thomas, George V., Gleave, Martin, Lloyd, Paul, Phillips, Tierney, McCarthy, Erin, Haffner, Michael C., Zoubeidi, Amina, Annala, Matti, Reiter, Robert E., Rettig, Matthew B., Witte, Owen N., Fong, Lawrence, Bose, Rohit, Huang, Franklin W., Luo, Jianhua, Bjartell, Anders, Lang, Joshua M., Mahajan, Nupam P., Lara, Primo N., Evans, Christopher P., Tran, Phuoc T., Posadas, Edwin M., He, Chuan, Cui, Xiao-Long, Huang, Jiaoti, Zwart, Wilbert, Gilbert, Luke A., Maher, Christopher A., Boutros, Paul C., Chi, Kim N., Ashworth, Alan, Small, Eric J., He, Housheng H., Wyatt, Alexander W., Quigley, David A., Feng, Felix Y.
Publicado 2022